FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/21/2024
Back to search
Official data from USPTO
BRIDGE CAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BRIDGE CAR
ST13
US500000079368443Class
5, 42
Filing
79368443
Registration
7416502
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
12/21/2024
Trademark type
Word
Nice classes
5, 42
Filing date
12/13/2022
Registration date
06/18/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/18/2024
Last transaction
06/18/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
BULLOFF, TOBY
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Biosceptre (Aust) Pty Ltd
Representatives
Timothy J. Kelly T.J. KELLY INTELLECTUAL PROPERTY LAW, P.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biopharmaceutical and pharmaceutical preparations for treatment of autoimmune diseasescancercardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; therapeutic agents for the treatment of autoimmune diseasescancercardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; veterinary preparationsnamely biopharmaceutical preparations for use in the treatment of autoimmune diseasescancertumorsblood-related diseasesinflammationcardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; veterinary preparationsnamely pharmaceutical preparations for use in the treatment of autoimmune diseasescancertumorsblood-related diseasesinflammationcardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; biological preparations for veterinary purposesnamely biopharmaceutical preparations for use in the treatment of autoimmune diseasescancertumorsblood-related diseasesinflammationcardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; biological preparations for veterinary purposesnamely pharmaceutical preparations for use in the treatment of autoimmune diseasescancertumorsblood-related diseasesinflammationcardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; cultures of microorganisms for medical and veterinary use; biological preparations for medical purposesnamely biopharmaceutical preparations for use in the treatment of autoimmune diseasescancertumorsblood-related diseasesinflammationcardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; biological preparations for medical purposesnamely pharmaceutical preparations for use in the treatment of autoimmune diseasescancertumorsblood-related diseasesinflammationcardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; drugs for medical purposesnamely biopharmaceutical preparations for use in the treatment of autoimmune diseasescancertumorsblood-related diseasesinflammationcardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; drugs for medical purposesnamely pharmaceutical preparations for use in the treatment of autoimmune diseasescancertumorsblood-related diseasesinflammationcardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; diagnostic preparations for medical purposes; enzymes for medical purposes; biochemical medicines for use in the treatment of autoimmune diseasescancertumorsblood-related diseasesinflammationcardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; vaccines; bioengineering pharmaceutical solutions for use in expanding cells for therapeutic use to patients with blood cancers and other diseases; biopharmaceuticalsnamely biopharmaceutical products for use in the treatment of autoimmune diseasescancertumorsblood-related diseasesinflammationcardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; cells and biological preparationsbloodstem cellsadult blood cellsimmune cellsimmunomodulatory cellsumbilical cord cellsumbilical cord bloodplacental tissue intended for medical and clinical useincludingbloodstem cellsadult blood cellsimmune cellsimmunomodulatory cellsumbilical cord cellsumbilical cord bloodplacental tissue; bioengineered cells for use in immunotherapies; diagnostic substances and diagnostic preparations for medical purposes; gene and cell therapy and prophylaxis productstherapeutic pharmaceuticals for use in the treatment of autoimmune diseasescancertumorsblood-related diseasesinflammationcardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; gene and cell therapy prophylaxis vector preparations for therapeutic purposes for use in the treatment of autoimmune diseasescancertumorsblood-related diseasesinflammationcardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; pharmaceutical preparations and productsnamely pharmaceutical preparations and products for use in the treatment of autoimmune diseasescancertumorsblood-related diseasesinflammationcardiovascular diseases and disordersendocrine diseases and disordersgastrointestinal diseases and disordersinfectious diseasespsychiatric and psychological diseases and disordersneurological diseases and disordersrespiratory diseases and disorders; pharmaceutical preparations in the nature of cell solutions to enable cell expansion for therapeutic purposes; reagents for ex vivo cell processing in particular media suitable for the expansion of cells for therapeutic purposes; cell products for therapeutic purposesnamely stem and progenitor celladult cellimmune cellcell therapy and gene therapy products; cells for medical purposes
Class 42
Analysis of biological samples; biopharmaceutical and pharmaceutical development and research and evaluation services in the field of cell based therapeutics and gene therapy for the treatment of diseaseinjuries and disorders; biotechnology laboratory services; medical and scientific laboratory services; scientificmedical and clinical research consultation services and scientificmedical and clinical research and development servicesincluding in the field of hematologyimmunologycancer researchdevelopmental biology and life sciencesbiotechnologymedical technologycell culturetissue engineeringgenetic engineeringregenerative medicineimmunotherapy and immunomodulation; medical and scientific researchconducting pre-clinical and clinical trials for others; pharmaceuticalmedicalscientificbiotechnologybiopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development in the field of computational biologybioinformaticsgenomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations and substances for use in clinical trials; chemical analysis; industrial design; conducting technical project studies in the fields of medicinebiotechnologytherapeuticspharmaceuticalsbiopharmaceuticalsbiotherapeuticsradiologycardiologyoncologyepidemiologypulmonologyneurologyhematologyendocrinologyotolaryngologygastroenterologynephrologygynecologyobstetricsurologyorthopedicsophthalmologypathologypediatricssurgerymedical geneticsmedical genomicsdermatologyimmunologypreventive medicine; research and development of new products for others; material testing; biological research; scientific laboratory services; scientific research; bacteriological research
Publications
History of USPTO decisions and trademark events.
29 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/04/2024
FIMP
FINAL DISPOSITION PROCESSED
12/04/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/18/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/18/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/02/2024
PUBO
PUBLISHED FOR OPPOSITION
04/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/27/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/13/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/29/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
02/28/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/28/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/28/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/28/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/08/2024
RFNT
REFUSAL PROCESSED BY IB
10/25/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/30/2023
RFRR
REFUSAL PROCESSED BY MPU
09/30/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/19/2023
CNRT
NON-FINAL ACTION WRITTEN
09/18/2023
DOCK
ASSIGNED TO EXAMINER
09/18/2023
MAFR
APPLICATION FILING RECEIPT MAILED
05/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/28/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/27/2023
Continuous trademark protection
Get notified about every new filing that threatens BRIDGE CAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.